Education, Science, Technology, Innovation and Life
Open Access
Sign In
  1. Home
  2. Journals
  3. MEDS Clinical Medicine
  4. Vol 4, Issue 5, 2023

Correlation between Gal-3, Klotho, Calcium and Phosphorus Metabolism Indicators and Cardiovascular Complications in Non Dialysis Patients with Chronic Kidney Disease

Download as PDF

DOI: 10.23977/medsc.2023.040520 | Downloads: 14 | Views: 312

Author(s)

Zhe Li 1, Jianlong Li 2, Qian Wang 1, Lin Li 1, Yan Gao 1, Chenchen Li 1, Qian Zhang 1, Xing Fan 1

Affiliation(s)

1 Department of Nephrology, Affiliated Hospital of Hebei University, Baoding, 071000, China
2 Division of Cardiology, Affiliated Hospital of Hebei University, Baoding, 071000, China

Corresponding Author

Jianlong Li

ABSTRACT

This article explores the correlation between Gal-3, Klotho, calcium and phosphorus metabolism indicators and cardiovascular disease in non dialysis CKD (stage 3-5) patients, summarizes their clinical characteristics, and provides a basis for the prevention and treatment of cardiovascular disease caused by CKD in clinical practice, providing reference for related research. This article selects 100 patients with stage 3-5 CKD who have not received renal replacement therapy. This question involves collecting general data from patients, collecting blood samples from patients, detecting serum calcium, serum phosphorus, Gal-3, and PTH levels at different stages, and calculating the product of calcium and phosphorus. Meanwhile, this study compared the incidence of hypocalcemia, hyperphosphatemia, and hyperparathyroidism at different stages. The research results showed that there was no statistically significant difference in blood calcium levels between CKD3 patients in stages 3 and 4 (P>0.05), but the blood calcium levels of CKD3 patients were significantly lower than those in stages 3 and 4. The difference between the two groups was statistically significant (P<0.05). The calcium and phosphorus products and PTH of patients in different stages gradually increased, but there was no significant difference in ALP levels in different stages (P>0.05). The incidence of hypocalcemia, hyperphosphatemia, high PTH, and calcium phosphate products>55 showed significant differences (P<0.01), and showed an increasing trend with stages, with the lowest in stage 3 and the highest in stage 5. This article analyzes the serum levels of Gal-3, Klotho, and calcium and phosphorus in non dialysis patients with CKD, which has important guiding significance for preventing cardiovascular complications, early intervention, and reducing patient mortality.

KEYWORDS

CKD; Non-dialysis patients; Calcium and phosphorus metabolism; CVD

CITE THIS PAPER

Zhe Li, Jianlong Li, Qian Wang, Lin Li, Yan Gao, Chenchen Li, Qian Zhang, Xing Fan, Correlation between Gal-3, Klotho, Calcium and Phosphorus Metabolism Indicators and Cardiovascular Complications in Non Dialysis Patients with Chronic Kidney Disease. MEDS Clinical Medicine (2023) Vol. 4: 148-153. DOI: http://dx.doi.org/10.23977/medsc.2023.040520.

REFERENCES

[1] Lunyera J, Scialla J J. Update on Chronic Kidney Disease Mineral and Bone Disorder in Cardiovascular Disease [J]. Seminars in Nephrology, 2018, 38(6):542-558.
[2] Panwar B, Mccann D, Olbina G, et al. Effect of calcitriol on serum hepcidin in individuals with chronic kidney disease: a randomized controlled trial [J]. Bmc Nephrology, 2018, 19(1):35.
[3] Gallant K M H, Spiegel D M. Calcium Balance in Chronic Kidney Disease [J]. Current Osteoporosis Reports, 2017, 81(12):1-8.
[4] Kan S, Zhang W, Mao J, et al. NF-kappa B activation contributes to parathyroid cell proliferation in chronic kidney disease [J]. Journal of nephrology. 2018(6):31.
[5] Sarnak M J, Amann K, Bangalore S, et al. Chronic Kidney Disease and Coronary Artery Disease[J]. Journal of the American College of Cardiology, 2019, 74(14):1823-1838.
[6] Sang-Ryol R, Park S K, Yong J J, et al. The Prevalence and Management of Anemia in Chronic Kidney Disease Patients: Result from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD) [J]. Journal of Korean Medical ence, 2017, 32(2):249.
[7] Vergnano D, Valle E, Bruni N, et al. Effectiveness of a Feed Supplement in Advanced Stages of Feline Chronic Kidney Disease [J]. Acta Scientiae Veterinariae, 2018, 44(1):8.
[8] Fuster J M B, Pilar Sanchís Cortés, Joan Perelló Bestard, et al. Plant phosphates, phytate and pathological calcifications in chronic kidney disease[J]. Nefrologia, 2017, 37(1):20.
[9] Salam S, Gallagher O, Gossiel F, et al. Vascular calcification relationship to vascular biomarkers and bone metabolism in advanced chronic kidney disease[J]. Bone, 2021, 143(3):115699.
[10] Van, den Broek, Chang Y M, Elliott J, et al. Chronic Kidney Disease in Cats and the Risk of Total Hypercalcemia [J]. Journal of Veterinary Internal Medicine, 2017, 31(2):465-475.

Subscription
E-Mail Alert
Most popular papers
Call for Special Issue
Publication Ethics & OA Statement
Plagiarism Policy
Contact Us
Downloads: 4561
Visits: 197592

Sponsors, Associates, and Links

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.